Top Tweets for #ProjectSiteSelector
Today, April 18 at 10:15 am ET, Rm W315 Conv Cntr - join #FDAOncology's @harpreet_md for a discussion of global clinical trial site selection at #AACR23 @AACR. #ProjectSiteSelector
#FDAOncology's @harpreet_md will lead a discussion of global clinical trial site selection at #AACR23 @AACR on April 18. #ProjectSiteSelector
#FDAOncology's @harpreet_md will lead a discussion of global clinical trial site selection at #AACR23 @AACR on April 18. #ProjectSiteSelector
#FDAOncology's @harpreet_md will lead a discussion of global clinical trial site selection at #AACR23 @AACR on April 18. #ProjectSiteSelector
#FDAOncology's @harpreet_md will lead a discussion of global clinical trial site selection at #AACR23 @AACR on April 18. #ProjectSiteSelector
An increasing number of drug applications to FDA rely on clinical trials conducted entirely outside the U.S. On Tuesday, April 18, @FDAOncology will lead a discussion of global trial site selection and trial diversity at #AACR23. https://t.co/aYW7Zoefnd

OCE issued a #funding announcement for conferences/workshops to explore challenges in clinical trial site selection for studies intended for regulatory approval of oncology indications.
Applications due March 7.
Learn more: https://t.co/YlOzB0YO8Q
#ProjectSiteSelector

It's #FundingFriday! Check out our #RFA to support conferences to explore challenges in clinical trial site selection for studies intended for regulatory approval of oncology indications. Applications due March 7.
https://t.co/YlOzB0YO8Q
#ProjectSiteSelector

OCE's Annual Report describes several projects to modernize evidence generation. #ProjectFrontRunner #ProjectPragmatica #ProjectSiteSelector #ProjectBeyondBreakthrough #OCEPFDD #OCERWE #OCECatalyst #OCEProjectEquity #OCEProjectOptimus #ProjectSignificant
https://t.co/fNVdszf1e7
#FDA #Funding Announcement for conferences/workshops to explore challenges in clinical trial site selection for studies intended for regulatory approval of oncology indications. Applications due March 7.
https://t.co/YlOzB0YO8Q
#ProjectSiteSelector

#FDA #Funding Announcement for conferences/workshops to explore challenges in clinical trial site selection for studies intended for regulatory approval of oncology indications. Letters of intent due Jan. 13. Applications due March 7.
https://t.co/YlOzB0YO8Q
#ProjectSiteSelector

#FDA #Funding Announcement for conferences/workshops to explore challenges in clinical trial site selection for studies intended for regulatory approval of oncology indications. Letters of intent due Jan. 13. Applications due March 7.
https://t.co/YlOzB0YO8Q
#ProjectSiteSelector

FDA Funding Announcement for conferences/workshops to explore challenges in clinical trial site selection for studies intended for regulatory approval of oncology indications. Letters of intent due Jan. 13. Applications due March 7.
https://t.co/YlOzB0YO8Q
#ProjectSiteSelector

Last Seen Hashtags on Sotwe
مبادل_الخبر
Seen from Saudi Arabia
young #nolimits
Seen from Canada
bara
giannamichaels
Seen from United Kingdom
ShoutMGB
Seen from United States
ometv #ชักว่าวโชว์
Seen from Thailand
นัดเย็ดเคหะบางพลี
Seen from Thailand
ลําปางนัดเย็ด
Seen from Thailand
wetpussy
Seen from United States
赤紫色の休憩謎
Seen from Japan
Most Popular Users

Elon Musk 
@elonmusk
240.8M followers

Barack Obama 
@barackobama
119.2M followers

Donald J. Trump 
@realdonaldtrump
111.7M followers

Cristiano Ronaldo 
@cristiano
111.2M followers

Narendra Modi 
@narendramodi
107M followers

Rihanna 
@rihanna
97.8M followers

NASA 
@nasa
92.2M followers

Justin Bieber 
@justinbieber
91M followers

KATY PERRY 
@katyperry
88M followers

Taylor Swift 
@taylorswift13
81.8M followers

Lady Gaga 
@ladygaga
73.4M followers

Virat Kohli 
@imvkohli
70.4M followers

Kim Kardashian 
@kimkardashian
69.9M followers

YouTube 
@youtube
68.7M followers

Bill Gates 
@billgates
64.1M followers

Neymar Jr 
@neymarjr
63.2M followers

The Ellen Show
@theellenshow
62.4M followers

CNN 
@cnn
61.9M followers

Selena Gomez 
@selenagomez
61.1M followers

X 
@x
60.8M followers

